首页 › 基金 › Verdad Advisers, LP › TARA

Verdad Advisers, LP 对 TARA 的持仓历史

PROTARA THERAPEUTICS INC · 医疗保健

Verdad Advisers, LP 在 Q3 2026 的 13F 申报中披露持有 TARA(PROTARA THERAPEUTICS INC)352,002 股,市值约 US$1.1M,约占其申报组合的 1.15%,在其申报持仓中市值排名第 18 位。 Verdad Advisers, LP 最近 2 个申报季度中有 2 个季度披露了 TARA 持仓,最早可追溯至 Q2 2026。

最新持仓 (Q3 2026)352.00K 股
申报持仓市值$1.07M
组合权重1.15%
首次申报Q2 2026
最近变动增持
更新于2026-11-16

最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR

Verdad Advisers, LP 对 TARA 的持仓演变

Verdad Advisers, LP 于 Q2 2026 首次披露 TARA 持仓:312,249 股(约 US$1.2M)。 在 2 次申报中,Verdad Advisers, LP 1 次增持、0 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 352,002 股、市值约 US$1.1M,环比增持 39,753 股。。

逐季持仓明细

季度股数金额变化
Q2 2026 312.25K $1.19M 新进
Q3 2026 352.00K $1.07M 增持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 TARA 与 13F 数据

TARA(PROTARA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 47 只申报持有 TARA,申报仓位最大的包括:Velan Capital Investment Management LP (US$8.7M), Rosalind Advisors, Inc. (US$7.3M), Sio Capital Management, LLC (US$6.1M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 TARA 的基金

查看 TARA 的全部基金持有人 →

常见问题

How long has Verdad Advisers, LP held TARA?

Verdad Advisers, LP has disclosed TARA holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Verdad Advisers, LP's current position in TARA?

As of Q3 2026, Verdad Advisers, LP holds 352.00K shares of TARA (PROTARA THERAPEUTICS INC), valued at $1.07M, representing 1.15% of its reported portfolio and ranking #18.

Has Verdad Advisers, LP been buying or selling TARA?

In the latest 13F filing (Q3 2026), Verdad Advisers, LP increased its position in TARA.

Which other funds hold TARA?

Other major institutional holders of TARA include Velan Capital Investment Management LP, Rosalind Advisors, Inc., Sio Capital Management, LLC, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.